RxDoctor Payments Data

Terence Ryan, MD

Family Medicine · Iron Mountain, MINPI 1639179567

Payments from drug & device makers

$275in general payments, 2019–2025

Across 25 payments — averaging $10.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$66
  • Abbott$44
  • Ferring Pharmaceuticals Inc.$31
  • Amgen$24
  • Merck$23
  • GSK$19
  • plus $68 from 5 others

What the payments were for

  • Speaking & faculty fees$135%
  • Food & beverage$24790%
  • Education$155%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$275 in reported general payments places this provider in the 50th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$531,994
Medicare patients
3,925
Services billed
38,757

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban195$182,829
JardianceEmpagliflozin159$153,075
OzempicSemaglutide119$140,848
TrulicityDulaglutide42$70,462
MounjaroTirzepatide33$34,149
XareltoRivaroxaban27$29,597
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$25,857
FarxigaDapagliflozin Propanediol17$24,282
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr24$20,697
Tresiba Flextouch U-200Insulin Degludec11$19,132
Breo ElliptaFluticasone/Vilanterol29$16,924
Stiolto RespimatTiotropium Br/Olodaterol Hcl17$13,505
Mesalamine11$12,833
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$11,233
Combivent RespimatIpratropium/Albuterol Sulfate16$9,730

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$11$182,829195 claims
Boehringer IngelheimJardiance, Stiolto Respimat, Combivent Respimat$15$176,310192 claims
Lilly USA, LLCTrulicity, Mounjaro$11$104,61075 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arexvy$19$70,593107 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Iron Mountain

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →